Impaired oxidative metabolism and lipid peroxidation in exercising muscle from ALS patients

Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders

Volumn 3, Issue 2, 2002, Pages 57-62

  Siciliano, Gabriele ^a   D'Avino, Carla ^a   Del Corona, Alberto ^a   Barsacchi, Renata ^a   Kusmic, Claudia ^a   Rocchi, Anna ^a   Pastorini, Elena ^a   Murri, Luigi ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

ALS; Exercise; Lactate; Lipoperoxides; Mitochondria

Indexed keywords

FREE RADICAL; LACTIC ACID; LIPID PEROXIDE; REACTIVE OXYGEN METABOLITE;

ADULT; AEROBIC CAPACITY; AEROBIC METABOLISM; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BICYCLE; CELL DEGENERATION; CELL LOSS; CLINICAL ARTICLE; CONTROLLED STUDY; EXERCISE TEST; FEMALE; HUMAN; HUMAN TISSUE; HYPOTHESIS; LACTATE BLOOD LEVEL; LIPID BLOOD LEVEL; LIPID PEROXIDATION; MALE; MITOCHONDRION; MOTONEURON; MUSCLE BIOPSY; MUSCLE DENERVATION; MUSCLE EXERCISE; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; REST;

AGED; AMYOTROPHIC LATERAL SCLEROSIS; BIOPSY; EXERCISE TEST; FEMALE; HUMANS; LACTIC ACID; LIPID PEROXIDES; MALE; MIDDLE AGED; MUSCLE, SKELETAL; STATISTICS, NONPARAMETRIC;

EID: 0036388399     PISSN: 14660822     EISSN: None     Source Type: Journal    
DOI: 10.1080/146608202760196011     Document Type: Article

References (37)

1. Bergeron C. Oxidative stress: its role in the pathogenesis of amyotrophic lateral sclerosis. J Neurol Sci 1995; 129 (suppl): 581-584.
2. Robberecht WL, de Jong JMBV. Oxidative stress in amyotrophic lateral sclerosis: pathogenic mechanism or epiphenomenon?. In: Brown RH, Meininger V, Swash M (eds.) Amyotrophic Lateral Sclerosis. London: Martin Dunitz, 2000: 211-22.
3. Rosen DR, Siddique T, Patterson D et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993; 362: 59-62.
4. Yim MB, Kang JH, Yim HS et al. A gain-of-function of an amyotrophic lateral sclerosis Cu,Zn-superoxide dismutase mutant: an enhancement of free radical formation due to a decrease in Km for hydrogen peroxide. Proc Natl Acad Sci USA 1996; 93: 5709-5714.
5. 2. Proc Natl Acad Sci USA 1998; 95: 6675-6680.
6. Ghadge GD, Lee JP, Bindokas VP et al. Mutant superoxide dismutase 1-linked familial amyotrophic lateral sclerosis: molecular mechanism of neuronal death and protection. J Neurosci 1997; 17: 8756-8766.
7. Liu R, Althaus JS, Ellerbrock BR et al. Enhanced oxygen radical production in a transgenic mouse model of familial amyotrophic lateral sclerosis. Ann Neurol 1998; 44: 763-770.
8. Bogdanov MB, Ramos LE, Xu Z, Beal MF. Elevated "hydroxyl radical" generation in vivo in an animal model of amyotrophic lateral sclerosis. J Neurochem 1998; 71: 1321-1324.
9. Beckman JS, Carson M, Smith CD, Koppenol WH. ALS, SOD and peroxyde nitrite. Nature 1993; 364: 584.
10. Keller JN, Kindy MS, Holtsberg FW, et al. Mitochondrial manganese superoxide dismutase prevents neural apoptosis and reduces ischemic brain injury: suppression of peroxynitrite production, lipid peroxidation, and mitochondrial dysfunction. J Neurosci 1998; 18: 687-697.
11. Skulachev VP. Role of uncoupled and non-coupled oxidations in maintenance of safely low levels of oxygen and its one-electron reductans. Q Rev Biophys 1996; 29: 696-699.
12. Vielhaber S, Kunz D, Winkler K et al. Mitochondrial DNA abnormalities in skeletal muscle of patients with sporadic amyotrophic lateral sclerosis. Brain 2000; 123: 1339-1348.
13. Swerdlow RH, Parks JK, Pattee G, Parker WD Jr. Role of mitochondria in amyotrophic lateral sclerosis. ALS 2000; 1:185-190
14. Borthwick GM, Johnson MA, Ince PG, Shaw PJ, Turnbull DM. Mitochondrial enzyme activity in amyotrophic lateral sclerosis: implications for the role of mitochondria in neutronal cell death. Ann Neurol 1999; 46: 787-790.
15. Vielhaber S, Winkler K, Kirches E et al. Visualization of defective mitochondrial function in skeletal muscle fibers of patients with sporadic amyotrophic lateral sclerosis. J Neurol Sci 1999; 169: 133-139.
16. Comi GP, Bordoni A, Salani S et al. Cytochrome c oxidase subunit I microdeletion in a patient with motor neuron disease. Ann Neurol 1998; 43: 110-116.
17. World Federation of Neurology Research Group. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. J Neurol Sci 1994; 124: 96-107.
18. Sorbini CA, Grassi V, Solinas E, Muiesan G. Arterial oxygen tension in relation to age in healthy subjects. Respiration 1968; 25: 3-13.
19. Siciliano G, Pastorini E, Pasquali L et al. Impaired oxidative metabolism in exercising muscle from ALS patients. J Neurol Sci 2001; 191: 61-65.
20. Hansen JE, Sue DY, Wasserman K. Predicted values for clinical exercise testing. Am Rev Respir Dis 1984; 129 (suppl): S49-S55.
21. Wasserman K, Whipp BJ, Koyal SN, Beaver WL. Anaerobic threshold and respiratory gas exchange during exercise. I Appl Physiol 1973; 35: 236-243.
22. Cesarone MR, Belcaro G, Carratelli M et al. A simple test to monitor oxidative stress. Int Angiol 1999; 18: 127-130.
23. Wiedeau-Pazos MW, Goto JJ, Rabizadeh S et al. Altered reactivity of superoxide dismutase in familial amyotrophic lateral sclerosis. Science 1996; 271: 515-518
24. Bruijn LI, Houseweart MK, Kato S et al. Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1. Science 1998; 281: 1851-1854.
25. Shibata N, Hirano A, Kobayashi M et al. Intense superoxide dismutase-1 immunoreactivity in intracytoplasmic hyaline inclusions of familial amyotrophic lateral sclerosis with posterior column involvement. J Neuropath Exp Neurol 1996; 55: 481-490.
26. Ince PG, Tomkins J, Slade JY et al. Amyotrophic lateral sclerosis associated with genetic abnormalities in the gene encoding Cu/Zn superoxide dismutase: molecular pathology of five new cases, and comparison with previous reports and 73 sporadic cases of ALS. J Neuropath Exp Neurol 1998; 57: 895-904.
27. Berlett B, Stachman E. Protein oxidation in ageing, disease and oxidative stress. J Biol Chem 1997; 272: 20313-20316.
28. Kwon OJ, Lee SM, Floyd RA et al. Thiol-dependent meta-catalyzed oxidation of copper, zinc superoxide dismutase. Biochim Biophys Acta 1998; 1387: 249-256.
29. Friguet B, Szweda LI. Inhibition of the multicatalytic proteinase (proteasome) by 4-hydroxy-2-nonenal cross linked protein. FEBS Lett 1997; 405: 21-25.
30. Ferrante RJ, Browne SE, Shinobu LA et al. Evidence of increased oxidative damage in both sporadic and familial amyotrophic lateral sclerosis. J Neurochem 1997; 69: 2064-2074.
31. Andrus PK, Flech TJ, Gurney ME et al. Protein oxidative damage in a transgenic mouse model of familial amyotrophic lateral sclerosis. J Neurochem 1998; 71: 2041-2048.
32. Bowling AC, Schulz JB, Brown RH Jr et al. Superoxide dismutase activity, oxidative damage and mitochondrial energy metabolism in familial and sporadic amyotrophic lateral sclerosis. J Neurochem 1993; 64: 2366-2369.
33. Shaw PJ, Ince PG, Falkous G et al. Oxidative damage to protein in sporadic motor neuron disease spinal cord. Ann Neurol 1995; 38: 691-695.
34. Trotti D, Rolfs A, Danbolt NC et al. SOD1 mutants linked to amyotrophic lateral sclerosis selectively inactivate a glial glutamate transporter. Nature Neurosci 1999; 2: 427-433.
35. Green DR, Read JC. Mitochondria and apoptosis. Science 1998; 281: 1309-1312.
36. Beal MF. Mitochondria and pathogenesis of ALS. Brain 2000; 123: 1291-1292.
37. Wiedemann FR, Manfredi G, Mawrin C, Beal MF, Schon EA. Mitochondrial DNA and respiratory chain function in spinal cords of ALS patients. J Neurochem 2002; 80: 616-625.